Two of the top five advances in cancer research cited in the 2011 annual progress report of the American Society of Clinical Oncology (ASCO) were led by Memorial Sloan-Kettering Cancer Center researchers. The report focused on improvements in the areas of personalized medicine and targeted therapies. ASCO is the world’s premier oncology professional society, representing more than 30,000 multidisciplinary medical professionals who treat people with cancer.
In a further demonstration of excellence, five Memorial Sloan-Kettering physician-scientists were selected to participate in the press program at ASCO’s annual meeting in June 2011. The press program highlights clinical cancer research that a panel of ASCO experts considers the most significant of the year and worthy of media attention. The five Memorial Sloan-Kettering studies represented nearly a quarter of all those on the press program. The areas of research covered were advances in melanoma, ovarian cancer, prostate cancer, and lung cancer.